[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4062/biomolther.2011.19.3.302

Cellular Signaling Molecules Associated with Peptidoglycan-Induced CCL3 Up-Regulation

Kim, Kang-Seung (Department of Pharmacology, School of Medicine, Pusan National University)
Rhim, Byung-Yong (Department of Pharmacology, School of Medicine, Pusan National University)
Eo, Seong-Kug (Laboratory of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University)
Kim, Koan-Hoi (Department of Pharmacology, School of Medicine, Pusan National University)

Publication Information

Biomolecules & Therapeutics / v.19, no.3, 2011 , pp. 302-307 More about this Journal

Abstract

Peptidoglycan (PGN) is detected in inflammatory cell-rich regions of human atheromatous plaques. The present study investigated the effects of PGN on CC chemokine ligand 3 (CCL3) expression, which is elevated in the atherosclerotic arteries, and determined cellular factors involved in PGN-mediated CCL3 up-regulation in mononuclear cells, with the goal of understanding the molecular mechanisms of inflammatory responses to bacterial pathogen-associated molecular patterns in diseased arteries. Exposure of human monocytic leukemia THP-1 cells to PGN resulted in enhanced secretion of CCL3 and profound induction of the CCL3 gene transcript. Both events were abrogated by oxidized 1-palmitoyl-2-arachidonosyl-sn-phosphatidylcholine, an inhibitor of Toll-like receptors 2/4. Pharmacological inhibitors such as U0126, SP6001250, Akt inhibitor IV, rapamycin, RO318220, diphenyleneiodonium chloride, and N-acetylcysteine also significantly attenuated PGN-mediated CCL3 up-regulation. However, polymyxin B, LY294002, and SB202190 did not influence CCL3 expression. We propose that PGN contributes to enhanced CCL3 expression in atherosclerotic plaques and that Toll-like receptors (TLR2), Akt, mTOR, mitogen-activated protein kinase, and reactive oxygen species are involved in that process.

Keywords

CCL3; Macrophages; Peptidoglycan;

Citations & Related Records

Times Cited By Web Of Science : 0 (Related Records In Web of Science)
Times Cited By SCOPUS : 1

Reference

1	Aukrust, P., Halvorsen, B., Yndestad, A., Ueland, T., Oie, E., Otterdal, K., Gullestad, L. and Damas, J. K. (2008) Chemokines and cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 28, 1909-1919. DOI
2	Cardoso, L. S., Araujo, M. I., Goes, A. M., Pacifi co, L. G., Oliveira, R. R. and Oliveira, S. C. (2007) Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb. Cell. Fact. 6, 1. DOI
3	Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W. and Meyer, J. (2002) Impact of infectious burden on extent and longterm prognosis of atherosclerosis. Circulation 105, 15-21. DOI
4	Taniguchi, A., Nishimura, F., Murayama, Y., Nagasaka, S., Fukushima, M., Sakai, M., Yoshii, S., Kuroe, A., Suzuki, H., Iwamoto, Y., Soga, Y., Okumura, T., Oqura, M., Yamada, Y., Seino, Y. and Nakai, Y. (2003) Porphyromonas gingivalis infection is associated with carotid atherosclerosis in non-obese Japanese type 2 diabetic patients. Metabolism 52, 142-145. DOI
5	Thobe, B. M., Frink, M., Hildebrand, F., Schwacha, M. G., Hubbard, W. J., Choudhry, M. A. and Chaudry, I. H. (2007) The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J. Cell Physiol. 210, 667-675. DOI
6	Veillard, N. R., Braunersreuther, V., Arnaud, C., Burger, F., Pelli, G., Steffens, S. and Mach, F. (2006) Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 188, 51-58. DOI
7	Wang, Z. M., Liu, C. and Dziarski, R. (2000) Chemokines are the main proinfl ammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 275, 20260-20267. DOI
8	Yoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R. and Golenbock, D. (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163, 1-5.
9	Lutgens, E., Faber, B., Schapira, K., Evelo, C. T., van Haaften, R., Heeneman, S., Cleutjens, K. B., Bijnens, A. P., Beckers, L., Porter, J. G., Mackay, C. R., Rennet, P., Bailly, V., Jarpe, M., Dolinski, B., Koteliansky, V., de Fougerolles, T., Daemen, M. J. (2005) Gene profi ling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation 111, 3443-3452. DOI
10	Liehn, E. A., Zernecke, A., Postea, O. and Weber, C. (2006) Chemokines: infl ammatory mediators of atherosclerosis. Arch. Physiol. Biochem. 112, 229-238. DOI
11	Manning, B. D. and Cantley, L. C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274. DOI
12	Menten, P., Wuyts, A. and Van Damme, J. (2002) Macrophage infl ammatory protein-1. Cytokine Growth Factor Rev. 13, 455-481. DOI
13	Miesel, R., Sanocka, D., Kurpisz, M. and Kroger, H. (1995) Antiinfl ammatory effects of NADPH oxidase inhibitors. Infl ammation 19, 347-362.
14	Saetre, T., Kahler, H., Foster, S. J. and Lyberg, T. (2000) Peptidoglycan and lipoteichoic acid, components of the streptococcal cell wall, have marked and differential effects on adhesion molecule expression and the production of reactive oxygen species in human whole blood leukocytes. Scand. J. Clin. Lab. Invest. 60, 311-321. DOI
15	Hayes, I. M., Jordan, N. J., Towers, S., Smith, G., Paterson, J. R., Earnshaw, J. J., Roach, A. G., Westwick, J. and Williams, R. J. (1998) Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler. Thromb. Vasc. Biol. 18, 397-403. DOI
16	Sipma, H., van der Zee, L., van den Akker, J., den Hertog, A. and Nelemans, A. (1996) The effect of the PKC inhibitor GF109203X on the release of Ca2+ from internal stores and Ca2+ entry in DDT1 MF-2 cells. Br. J. Pharmacol. 119, 730-736. DOI ScienceOn
17	Spagnuolo, G., D'Anto, V., Cosentino, C., Schmalz, G., Schweikl, H. and Rengo, S. (2006) Effect of N-acetyl-L-cysteine on ROS production and cell death caused by HEMA in human primary gingival fi broblasts. Biomaterials 27, 1803-1809. DOI
18	Hahn-Windgassen, A., Nogueira, V., Chen, C. C., Skeen, J. E., Sonenberg, N. and Hay, N. (2005) Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 280, 32081-32089. DOI
19	Holven, K. B., Myhre, A. M., Aukrust, P., Hagve, T. A., Ose, L. and Nenseter, M. S. (2003) Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender. Eur. Heart J. 24, 1756-1762. DOI
20	Kawai, T. and Akira, S. (2006) TLR signaling. Cell Death Differ. 13, 816-825. DOI
21	Laman, J. D., Schoneveld, A. H., Moll, F. L., van Meurs, M. and Pasterkamp, G. (2002) Signifi cance of peptidoglycan, a proinfl ammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am. J. Cardiol. 90, 119-123. DOI
22	Asehnoune, K., Strassheim, D., Mitra, S., Kim, J. Y. and Abraham, E. (2005) Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB. Cell Signal. 17, 385-394. DOI
23	Langer, M., Malykhin, A., Maeda, K., Chakrabarty, K., Williamson, K. S., Feasley, C. L., West, C. M., Metcalf, J. P. and Coggeshall, K. M. (2008) Bacillus anthracis peptidoglycan stimulates an infl ammatory response in monocytes through the p38 mitogen-activated protein kinase pathway. PLoS One 3, e3706. DOI
24	Lee, S. A., Kim, S. M., Son, Y. H., Lee, C. W., Chung, S. W., Eo, S. K., Rhim, B. Y. and Kim, K. (2011) Peptidoglycan enhances secretion of monocyte chemoattractants via multiple signaling pathways. Biochem. Biophys. Res. Commun. 408, 132-138. DOI
25	Libby, P. (2002) Infl ammation in atherosclerosis. Nature 420, 868-874. DOI